Evaluation of the Renal Congestion, Perfusion and Function Before and After Diuretic Treatment in the ICU
NCT ID: NCT03704844
Last Updated: 2019-05-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
120 participants
OBSERVATIONAL
2018-12-01
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this trial is to study the reversibility of kidney congestion under diuretic therapy and assess through echodoppler parameters if it can improve renal perfusion and function in congestive ICU patients.
It could in fine lead to a better identification of patients that could benefit from diuretic therapy in the ICU.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Venous Ultrasound Guided Organ Decongestion in Patients Hospitalized with Acute Decompensated Heart Failure
NCT06714409
IVC and Lung Ultrasound B-lines Guided Decongestion in Critically Ill ESKD Patients With Heart Failure
NCT06373575
Optimized Treatment of Pulmonary Edema or Congestion
NCT05276219
Bedside Ultrasound-guided Volume Management and Discharge Timing for Patients With Heart Failure During Hospitalization: A Randomized Controlled Trial
NCT07046169
Echocardiography in Critically-ill Patients With COVID-19 Pneumonia
NCT04414410
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with renal congestion
non applicable
non applicable
Patients without renal congestion
non applicable
non applicable
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
non applicable
non applicable
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* under furosemide treatment
Exclusion Criteria
* uncontrolled shock (MAP\<65mmHg)
* abdominal compartment syndrome
* diuretic administration in the 6 hours prior to inclusion
* renal replacement therapy or stage 4-5 chronic kidney disease
* atrial fibrillation
* no monitoring of CVP / invasive arterial pressure
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Strasbourg, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Amiens-Picardie
Amiens, , France
CHU de Dijon
Dijon, , France
Les Hôpitaux Universitaires de Strasbourg
Strasbourg, , France
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
7148
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.